- May 6, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Synonyms :
Class :
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
interaction raises immunosuppressive effects and risk of infection
it may increase the risk of adverse effects of anakinra
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
may increase the immunosuppressive effect of other antirheumatic drugs
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
when both drugs are combined, there may be an increased metabolism of etoposide
when both drugs are combined, there may be a high metabolism of paclitaxel
when both the drugs are combined, the metabolism of carmustine increases
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk of serious infections
both, if used simultaneously, show immunosuppression risk of infection increases on administering both the drugs simultaneously
When both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections